Where does Rebiotix Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Rebiotix Inc. ranks #9,355 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Rebiotix Inc. hold?

Rebiotix Inc. holds 34 US utility patents granted between 2016 and 2024, spanning 8 technology areas.

What is Rebiotix Inc.'s Innovation Score?

Rebiotix Inc. has an Innovation Score of 36.0 out of 100 (top 48% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Rebiotix Inc. focus on?

Rebiotix Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 34 patents, ranking #650 of 7,163 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Rebiotix Inc.'s patent grant rate increasing or decreasing?

Rebiotix Inc.'s recent grant velocity is -11% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Rebiotix Inc.'s patents?

Rebiotix Inc.'s patents average 16.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Rebiotix Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Rebiotix Inc.

USPTO PatentsView assignee record - 34 granted patents across 8 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Rebiotix ranks #9,355 of 49,997 tracked US assignees by granted-patent volume, with 34 patents across 8 technology areas.

#9,355
of 49,997 US assignees by volume: Top 48%
by Innovation Score (36.0/100): 16.6
avg claims per patent: -11%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9355 · US Corporation #9,355 · 34 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 34 grants
UPPER-Q #9,355/49,997
PHOTO-FINISH Rawlings Sporting…
CPC-NARROW A61K · 8 areas
INNOV-THIN 36.0/100
CLAIMS-RICH 16.6 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -11% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Rawlings Sporting Goods Company, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Rebiotix’s 36.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.3 pts (34%) Velocity 3.8 pts (11%) Breadth 10.0 pts (28%) Claim depth 9.9 pts (28%)

Qualcomm Incorporated · highest

85
Cosmo OIL · near

36
JST Performance · near

36
Rebiotix · this assignee

36
Thalmic Labs · near

36
Zume · near

36
3D Lighting… · lowest

7

What this shows Rebiotix's Innovation Score is 36.0/100 (top 48% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Rebiotix?

Each dot is one of Rebiotix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rebiotix’s own 16.6 claims/patent is at or below the 17.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Rebiotix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Rebiotix's grants concentrate

Rebiotix Inc. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2019 (9 grants) versus a trough of 1 in 2021. By volume, Rebiotix sits between Rawlings Sporting Goods Company, Inc. and Saint-gobain Performance Plastics Pampus GMBH.

Rebiotix's three-year grant acceleration

Rebiotix Inc. shows 9 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Rawlings Sporting…

34
Rivada Networks

34
Rovl Guides

34
Rxsafe

34
Robertson Intelle…

34
Rock Solid Indust…

34
S9

34
Saint-gobain Perf…

34
Rebiotix ◀

34

What this shows Rebiotix holds 34 patents at rank #9,358, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Rebiotix

By rank, the assignees closest to #9,358 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Rebiotix's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Rebiotix, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Rebiotix ranks #650 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (36 here).

Zume, Inc. 36 Thalmic Labs Inc. 36 Cosmo OIL Co., Ltd. 36 JST Performance, LLC 36

Rebiotix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 48% higher than 52% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Rebiotix Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	4	11.8%
2017	5	14.7%
2019	9	26.5%
2020	6	17.6%
2021	1	2.9%
2022	1	2.9%
2023	3	8.8%
2024	5	14.7%

Which technologies does Rebiotix Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 34

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 20

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 18

Y02A - Technologies FOR Adaptation TO Climate Change 14

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 12

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 12

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 12

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 6

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Rebiotix Inc.'s patent record in context - here's where to go next.

Rebiotix Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #9,355 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Rebiotix Inc. against Rawlings Sporting Goods Company, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.